It causes snoring at night and leaves people exhausted by day, but could a new generation of treatments – from a daily pill to a stick-on patch worn under the chin – finally transform how obstructive sleep apnoea is treated?
Affecting about 8 million people in the UK, obstructive sleep apnoea (OSA) occurs when throat muscles relax too much during sleep, cutting off breathing for seconds at a time and temporarily starving the brain of oxygen.
This disrupts sleep and is also linked to a greater risk of heart disease and stroke over time, as repeated drops in oxygen can cause surges
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
